Stack
Analyzer
Choose the combination you use; See interaction & security auditing, function axis coverage and redundancy/gap notes on a single screen.
Substances in combination
Maximum 8 items. Your selection is saved in the link; you can share.
Interaction & security
- medium riskOmega-3 DHA/EPA
Omega-3 DHA/EPA - dikkat
High-dose omega-3 is not risk-free for everyone. Large trials using 4 g/day in adults with cardiovascular disease or high risk found increased atrial fibrillation risk. Anticoagulants, pregnancy or surgery require medical review of dose and product. NIH ODS: High doses may have antiplatelet effects, but most research in warfarin users found no significant change in anticoagulant status. This proves neither increased bleeding nor no risk for every product/drug pair; monitoring is assessed with the care team.
Combination profile
Functional axis coverage
Source distribution
Doğal ×1
These results are screening warnings. Severity describes a potential concern, not its probability or the certainty of clinical evidence. Some rules extrapolate from mechanisms or drug classes; an absent warning does not establish safety.
Looking for a new combination? Start from a goal with the Nootropic Finder or browse the ready-made stacks.
FDA: Mixing Medications and Dietary Supplements Can Endanger Your Health